Log in

OTCMKTS:BNOEF - Bionomics Stock Price, Forecast & News

0.00 (0.00 %)
(As of 03/27/2020 04:00 PM ET)
Today's Range
Now: $0.02
50-Day Range
MA: $0.04
52-Week Range
Now: $0.02
Volume17,600 shs
Average Volume6,081 shs
Market Capitalization$11.58 million
P/E RatioN/A
Dividend YieldN/A
Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancer in Australia, France, and the United States. It operates through Drug Discovery and Development, and Contract Services segments. The company's product pipeline includes BNC210, a negative allosteric modulator, which is in Phase II clinical trial for the treatment of generalized anxiety disorder, as well as is in Phase II clinical trial in patients with post-traumatic stress disorder; BNC375, a small molecule therapeutics for the treatment of cognitive impairment in Alzheimer's disease; BNC101, a monoclonal antibody that targets cancer stem cells; and BNC105, a vascular disrupting agent for the treatment of cancer, as well as disrupts the blood vessels that nourish tumors in cancer treatment. It also offers Multicore, a suite of integrated synthetic methods that gives access to complex drug-like molecules; and ionX, an integrated platform of genomics discoveries and technologies that serves as the foundation for Bionomics' CNS drug discovery and development, as well as contract research services. The company has a collaborative partnership with Merck & Co., Inc. Bionomics Limited was founded in 1998 and is based in Thebarton, Australia.
Read More

Industry, Sector and Symbol

Industry Noncommercial research organizations



Sales & Book Value

Annual SalesN/A



Market Cap$11.58 million
Next Earnings DateN/A
OptionableNot Optionable

Receive BNOEF News and Ratings via Email

Sign-up to receive the latest news and ratings for BNOEF and its competitors with MarketBeat's FREE daily newsletter.

Bionomics (OTCMKTS:BNOEF) Frequently Asked Questions

How has Bionomics' stock been impacted by COVID-19 (Coronavirus)?

Bionomics' stock was trading at $0.03 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, BNOEF stock has decreased by 20.0% and is now trading at $0.0240. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Bionomics?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bionomics in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Bionomics.

Has Bionomics been receiving favorable news coverage?

News articles about BNOEF stock have trended neutral recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Bionomics earned a coverage optimism score of 0.1 on InfoTrie's scale. They also gave news stories about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the immediate future. View the latest news aboutBionomics.

Who are some of Bionomics' key competitors?

What other stocks do shareholders of Bionomics own?

Who are Bionomics' key executives?

Bionomics' management team includes the following people:
  • Dr. Errol B. De Souza, Exec. Chairman (Age 66)
  • Mr. Jack Moschakis BEc, DipLaw(BAB), GDipBA, FCIS, Legal Counsel & Company Sec.
  • Prof. Paul Rolan, Consultant Medical Officer of Clinical Neuroscience

What is Bionomics' stock symbol?

Bionomics trades on the OTCMKTS under the ticker symbol "BNOEF."

How do I buy shares of Bionomics?

Shares of BNOEF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Bionomics' stock price today?

One share of BNOEF stock can currently be purchased for approximately $0.02.

How big of a company is Bionomics?

Bionomics has a market capitalization of $11.58 million.  View additional information about Bionomics.

MarketBeat Community Rating for Bionomics (OTCMKTS BNOEF)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  45 (Vote Outperform)
Underperform Votes:  59 (Vote Underperform)
Total Votes:  104
MarketBeat's community ratings are surveys of what our community members think about Bionomics and other stocks. Vote "Outperform" if you believe BNOEF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BNOEF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel